Luvo Health vs RxSpan MD
Two GLP-1 desks, one scoreboard. We put Luvo Health and RxSpan MD head-to-head on the published Brief Score — the same six factors, scored the same way.
Luvo Health
The verdict
Luvo Health takes this head-to-head.
Luvo Health scores 79 to 72 on our six-factor Brief Score — A longevity-leaning telehealth brand ("Longevity-focused care for real life") that publishes a full 4/12/24/52-week term ladder for compounded semaglutide and tirzepatide, plus a real brand-name Ozempic route and a separate NAD+/Sermorelin longevity line — all static pricing, no quiz.
That doesn't make RxSpan MD a bad call — it's best for readers who want to check who is prescribing and who is compounding before they buy, and who will change the pre-selected plan back to monthly unless they actually mean to pay a year up front. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Luvo Health | RxSpan MD | |
|---|---|---|
| Brief Score | 79/100 (C) | 72/100 (C) |
| Semaglutide | $249/4-wk injection or $279/4-wk tablets — as low as $45/wk (injection), but only on a prepaid 52-wk term | $249/mo month-to-month, compounded — the funnel pre-selects a 3-month prepay at $657 up front, and its cheapest rung is $2,327 for a year in one charge |
| Tirzepatide | $339/4-wk term — as low as $67/wk, but only on a prepaid 52-wk term | $329/mo month-to-month, compounded — 3 months bills $927 up front, 12 months $3,228 |
| Coverage | Not disclosed | All 50 states claimed — asynchronous review is not available in all of them |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
Luvo Health: 4-week entry prices unchanged from our last reading ($249 semaglutide injection / $339 tirzepatide), but this pass confirmed the full term ladder: both molecules get progressively cheaper per week on 12-, 24- and 52-week prepaid terms, down to $45/wk and $67/wk respectively — real savings, in exchange for a real lump-sum commitment.
RxSpan MD: First reading of the live catalog, 8 August 2026, replacing a dataset line that had never been checked against it. Month-to-month is $249 semaglutide and $329 tirzepatide; the ladder runs down to $194 and $269 a month, but only by paying $2,327 or $3,228 in a single charge. The cheapest GLP-1 figures RxSpan publishes anywhere — $179 and $199, in its own product API — are on no storefront page and buy nothing.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.